89 related articles for article (PubMed ID: 20230395)
1. A novel missense mutation c.470 A>C (p.D157A) in the SLC40A1 gene as a cause of ferroportin disease in a family with hyperferritinaemia.
Saja K; Bignell P; Robson K; Provan D
Br J Haematol; 2010 Jun; 149(6):914-6. PubMed ID: 20230395
[No Abstract] [Full Text] [Related]
2. Genetic and clinical heterogeneity of ferroportin disease.
Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
[TBL] [Abstract][Full Text] [Related]
3. Novel human pathological mutations. Gene symbol: SLC40A1. Disease: haemochromatosis, type 4.
Relvas L; Claro MT; Bento MC; Ribeiro ML
Hum Genet; 2009 Apr; 125(3):338. PubMed ID: 19309784
[No Abstract] [Full Text] [Related]
4. G80S-linked ferroportin disease: the first clinical description in a Greek family.
Mougiou A; Pietrangelo A; Caleffi A; Kourakli A; Karakantza M; Zoumbos N
Blood Cells Mol Dis; 2008; 41(1):138-9. PubMed ID: 18420432
[No Abstract] [Full Text] [Related]
5. Hemochromatosis caused by mutations in the iron-regulatory proteins ferroportin and H ferritin.
Press RD
Mol Diagn; 2001 Dec; 6(4):347. PubMed ID: 11774199
[No Abstract] [Full Text] [Related]
6. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin: A recurrent cause of haemochromatosis in China.
Zhang W; Xu A; Li Y; Zhao S; Zhou D; Wu L; Zhang B; Zhao X; Wang Y; Wang X; Duan W; Wang Q; Nan Y; You H; Jia J; Ou X; Huang J;
Liver Int; 2019 Jun; 39(6):1120-1127. PubMed ID: 30500107
[TBL] [Abstract][Full Text] [Related]
7. A novel ferroportin mutation in a Canadian family with autosomal dominant hemochromatosis.
Morris TJ; Litvinova MM; Ralston D; Mattman A; Holmes D; Lockitch G
Blood Cells Mol Dis; 2005; 35(3):309-14. PubMed ID: 16111902
[TBL] [Abstract][Full Text] [Related]
8. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features.
Sham RL; Phatak PD; West C; Lee P; Andrews C; Beutler E
Blood Cells Mol Dis; 2005; 34(2):157-61. PubMed ID: 15727899
[TBL] [Abstract][Full Text] [Related]
9. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
[TBL] [Abstract][Full Text] [Related]
10. Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV.
Speletas M; Kioumi A; Loules G; Hytiroglou P; Tsitouridis J; Christakis J; Germenis AE
Blood Cells Mol Dis; 2008; 40(3):353-9. PubMed ID: 17997113
[TBL] [Abstract][Full Text] [Related]
11. Ferroportin disease: A novel SLC40A1 mutation.
Ravasi G; Pelucchi S; Russo A; Mariani R; Piperno A
Dig Liver Dis; 2020 Jun; 52(6):688-690. PubMed ID: 32360131
[No Abstract] [Full Text] [Related]
12. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
[TBL] [Abstract][Full Text] [Related]
13. A Japanese family with ferroportin disease caused by a novel mutation of SLC40A1 gene: hyperferritinemia associated with a relatively low transferrin saturation of iron.
Koyama C; Wakusawa S; Hayashi H; Ueno T; Suzuki R; Yano M; Saito H; Okazaki T
Intern Med; 2005 Sep; 44(9):990-3. PubMed ID: 16258219
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness of a diagnostic algorithm hyperferritinemia: A case report of a Spanish family with hereditary hemochromatosis and mutation in SLC40A1 gene].
Vargas JA; Muñoz A; Samper B; Bornstein B
Med Clin (Barc); 2015 Jul; 145(1):42-3. PubMed ID: 25441019
[No Abstract] [Full Text] [Related]
15. The
Ka C; Guellec J; Pepermans X; Kannengiesser C; Ged C; Wuyts W; Cassiman D; de Ledinghen V; Varet B; de Kerguenec C; Oudin C; Gourlaouen I; Lefebvre T; Férec C; Callebaut I; Le Gac G
Haematologica; 2018 Nov; 103(11):1796-1805. PubMed ID: 30002125
[TBL] [Abstract][Full Text] [Related]
16. Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del "loss of function" mutations in ferroportin disease.
Lim FL; Dooley JS; Roques AW; Grellier L; Dhillon AP; Walker AP
Blood Cells Mol Dis; 2008; 40(3):328-33. PubMed ID: 18160317
[TBL] [Abstract][Full Text] [Related]
17. Novel gain of function mutation in the SLC40A1 gene associated with hereditary haemochromatosis type 4.
Chen SR; Yang LQ; Chong YT; Jie YS; Wu YK; Yang J; Lin GL; Li XH
Intern Med J; 2015 Jun; 45(6):672-6. PubMed ID: 26059880
[TBL] [Abstract][Full Text] [Related]
18. Ferroportin (SLC40A1) gene in thalassemic patients of Indian descent.
Agarwal S; Sankar VH; Tewari D; Pradhan M
Clin Genet; 2006 Jul; 70(1):86-7. PubMed ID: 16813613
[No Abstract] [Full Text] [Related]
19. Characterization of three novel pathogenic SLC40A1 mutations and genotype/phenotype correlations in 7 Italian families with type 4 hereditary hemochromatosis.
Majore S; Bonaccorsi di Patti MC; Valiante M; Polticelli F; Cortese A; Di Bartolomeo S; De Bernardo C; De Muro M; Faienza F; Radio FC; Grammatico P; Musci G
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):464-470. PubMed ID: 29154924
[TBL] [Abstract][Full Text] [Related]
20. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis.
Njajou OT; Vaessen N; Joosse M; Berghuis B; van Dongen JW; Breuning MH; Snijders PJ; Rutten WP; Sandkuijl LA; Oostra BA; van Duijn CM; Heutink P
Nat Genet; 2001 Jul; 28(3):213-4. PubMed ID: 11431687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
